Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms

Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

Catriona McLean, Robert A. Cherny, Fiona Fraser et al. · Annals of Neurology · 1999 · 1.8K citations

Life Sciences, Neurobiology, Neuroscience +17

PSD-95 Involvement in Maturation of Excitatory Synapses

Alaa El-Husseini, Eric Schnell, Dane M. Chetkovich et al. · Science · 2000 · 1.3K citations

Life Sciences, Neurobiology, Neuroscience +17

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Christopher J. Phiel, Virginia M.‐Y. Lee, Peter S. Klein · Nature · 2003 · 1.2K citations

Life Sciences, Biochemistry, Molecular Biology +12

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Mónica García‐Alloza, Elissa M. Robbins, Sandy Zhang-Nunes et al. · Neurobiology of Disease · 2006 · 748 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Expression of Concern: Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols <i>in vitro</i>: implications for the prevention and therapeutics of Alzheimer's disease

Kenjiro Ono, Yuji Yoshiike, Akihiko Takashima et al. · Journal of Neurochemistry · 2003 · 683 citations

Life Sciences, Biochemistry, Neuroscience +16